Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Rushnet Inc RSHN

RushNet, Inc. operates under the name HeliosDX. HeliosDX is a national clinical reference laboratory offering high-complexity urine drug testing (UDT), behavioral drug testing, allergy droplet cards, oral fluids, and infectious disease (PCR). The Company provides management services and insurance billing services principally to clinical reference laboratories. It provides PGX testing through... see more

PINL:RSHN - Post Discussion

Rushnet Inc > RSHN Closes its 2nd Recent Acquisition
View:
Post by AveragePenny on Aug 23, 2021 3:16pm

RSHN Closes its 2nd Recent Acquisition

https://www.otcmarkets.com/stock/RSHN/news?id=317614

Grandeza was formed in January 2021, as a spin-out of its operations from heliosDX. Grandeza is a billing and coding company in the Healthcare sector. Currently, Grandeza has three main laboratories in which it processes billing while providing other services. In the coming months, Grandeza expects rapid growth as it intends to add a department within the company focused on temporary healthcare employment. More information will be disclosed in the future about how Grandeza intends to tackle this market with an acquisition of its own.

Through this calendar year (August 20, 2021), Grandeza Healthcare has produced revenues of $1,097,879 with a profit of $40,699. Grandeza Healthcare has seen its revenue continue to increase month-over-month and quarter-over-quarter. With the recent customer addition, Grandeza should achieve approximately $1,646,818 of revenues in 2021. Danielle Bauer, CEO of Grandeza Healthcare, says, "I am excited about this opportunity for Grandeza Healthcare. We provide a tremendous service to our clients and believe our billing practices and staff are some of the best in the industry. Additionally, given the heliosDX acquisitions in the healthcare industry, each contemplated to be a customer of Grandeza, our opportunities abound."

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities